Representative April Delaney Stocks

On February 3, 2026, Representative April Delaney of US Congress acquired under $15k worth of Laboratory's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 11 other transactions of April Delaney.
2026-02-03Acquired Under $15KLH LaboratoryInsidersVerify
2026-01-06Acquired Under $15KTDY Teledyne TechnologiesInsidersVerify
2025-12-09Acquired Under $15KMKL MarkelInsidersVerify
2025-11-05Acquired $15K to $50KNDAQ Nasdaq IncInsidersVerify
2025-10-07Acquired Under $15KMIDD Middleby CorpInsidersVerify
2025-09-03Acquired $15K to $50KMKL MarkelInsidersVerify
2025-08-06Acquired Under $15KMKL MarkelInsidersVerify
2025-07-03Acquired Under $15KMKL MarkelInsidersVerify
2025-06-03Acquired Under $15KMKL MarkelInsidersVerify
2025-05-02Acquired Under $15KMKL MarkelInsidersVerify
2025-04-03Acquired $15K to $50KMKL MarkelInsidersVerify
View All Elective Officials  

Risk-return Landscape of April Delaney's positions

  Expected Return   
       Risk  

Assets Rated by Market Efficiency

Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
EfficiencyMarket RiskExp ReturnPrice
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.